Trehalose-6,6'-dibehenate

Trehalose-6,6'-dibehenate

• CAS Number: 66758-35-8
• UNSPSC Description: Trehalose-6,6'-dibehenate is a bioactive glycolipid that can be used to prepare vaccine adjuvant[1].
• Target Antigen: Others
• Type: Reference compound
• Related Pathways: Others
• Applications: COVID-19-immunoregulation
• Field of Research: Inflammation/Immunology
• Assay Protocol: https://www.medchemexpress.com/trehalose-6-6-dibehenate.html
• Purity: 98.0
• Solubility: DMF : 0.5 mg/mL (ultrasonic;warming;heat to 60°C)
• Smiles: CCCCCCCCCCCCCCCCCCCCCC(OC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@@H]1O[C@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)COC(CCCCCCCCCCCCCCCCCCCCC)=O)=O
• Molecular Weight: 987.43
• References & Citations: [1]Yu H, et, al. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells. Infect Immun. 2010 May;78(5):2272-82.
• Shipping Conditions: Room Temperature
• Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
• Clinical Information: Phase 3